Market capitalization | $663.40m |
Enterprise Value | $637.98m |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 3.94 |
P/S ratio (TTM) P/S ratio | 4.10 |
P/B ratio (TTM) P/B ratio | 1.77 |
Sales growth (TTM) Sales growth | 24.04% |
Turnover (TTM) Turnover | $161.83m |
As a free StocksGuide basic user, you can view the scores for all 6,951 shares worldwide.
7 Analysts have issued a OrthoPediatrics Corp. forecast:
7 Analysts have issued a OrthoPediatrics Corp. forecast:
Mar '24 |
+/-
%
|
||
Turnover | 162 162 |
24%
24%
|
|
Gross income | 101 101 |
24%
24%
|
|
EBITDA | -8.04 -8.04 |
14%
14%
|
EBIT (operating result) EBIT | -27 -27 |
14%
14%
|
Net profit | -22 -22 |
756%
756%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
Head office | United States |
CEO | David Bailey |
Employees | 247 |
Founded | 2006 |
Website | www.orthopediatrics.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.